CANNARA BIOTECH INC.
Ownership & governance
Executives 5Directors 5Avg age 56Avg tenure 5.8y
ZK
Zohar Krivorot
Chief Executive Officer
Age 50Since 2018-12-30Profile →
+9
Executives5
Board of directors5
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Zohar Krivorot | 25.83 % | 25,519,207 |
| Derek Stern | 24.49 % | 24,193,960 |
| Nicholas Sosiak | 0.8318 % | 821,715 |
| Donald Olds | 0.3252 % | 321,200 |
| AdvisorShares Investments LLC | 0.251 % | 247,894 |
Catalog · 2026-07-09
Registry officers10
| Name | Role | Since | Shares |
|---|---|---|---|
| Avi Krivorot | Chief Tech/Sci/R&D Officer | 2021-03-31 | - |
| Nicholas Sosiak | Director of Finance/CFO | 2020-11-07 | - |
| Zohar Krivorot | Chairman | — | - |
| Zohar Krivorot | Chief Executive Officer | 2018-12-30 | - |
| Derek Stern | Director/Board Member | 2018-12-30 | - |
| Donald Olds | Director/Board Member | 2020-11-09 | - |
| Justin Cohen | Director/Board Member | 2025-03-23 | - |
| Mary Durocher | Director/Board Member | 2020-05-24 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 3.38Range 3–4Analysts 4
3Mean 3.384
- Buy 4
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.